Danaparoid and prothrombin time prolonged Patient Reports February 13, 2012

Danaparoid Side Effects Report #5022100-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 23, 2006. Female patient, 88 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood potassium decreased, blood urea increased, c-reactive protein increased, fibrin d dimer increased, prothrombin time prolonged, thrombocytopenia. Danaparoid dosage: unknown. During the same period patient was treated with POLYGLOBIN, PRIMAXIN, DOPAMINE, FLOMOXEF. Patient recovered.

Danaparoid Side Effects Report #5121582-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 21, 2006. Male patient, 87 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: catheter related complication, gastrointestinal haemorrhage, prothrombin time prolonged. Danaparoid dosage: unknown. During the same period patient was treated with PROPOFOL, DOPAMINE, METHYLPREDNISOLONE SUCCINATE, ANTITHROMBIN III, DOUBUTAMINE HYDROCHLORIDE, NOREPINEPHRINE BITARTRATE, MEROPENEM TRIHYDRATE, IMMUNE GLOBULIN INTRAVENOUS. Patient recovered.

Danaparoid Side Effects Report #5020297-7
Danaparoid side effect was reported by a Consumer or non-health professional from ARMENIA on May 24, 2006. Female patient, 81 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, brain oedema, cerebral haemorrhage, gastrointestinal haemorrhage, hypokalaemia, melaena, platelet count decreased, prothrombin time prolonged, subdural haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE, DOPAMINE, LASIX, OMEPRAZOLE, GLYCEROL, CARBAZOCHROME SULFONATE. Patient died.

Danaparoid Side Effects Report #5020449-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 24, 2006. Female patient, 81 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, brain oedema, gastrointestinal haemorrhage, hypokalaemia, melaena, platelet count decreased, prothrombin time prolonged, subdural haemorrhage, white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE, DOPAMINE, LASIX, OMEPRAZOLE, GLYCEROL, CARBAZOCHROME SULFONATE. Patient died.


Danaparoid Side Effects Report #5083999-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 07, 2006. Male patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood lactate dehydrogenase increased, blood potassium increased, blood urea increased, prothrombin time prolonged, subdural haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with MENATETRENONE, MAGNESIUM OXIDE, FAMOTIDINE, FUROSEMIDE, ALLOPURINOL. Patient died.

Danaparoid Side Effects Report #5029101-4
Danaparoid side effect was reported by a Health Professional from JAPAN on June 07, 2006. Male patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood lactate dehydrogenase increased, blood potassium increased, blood urea increased, platelet count decreased, prothrombin time prolonged, subdural haematoma. Danaparoid dosage: unknown. During the same period patient was treated with MENATETRENONE, MAGNESIUM OXIDE, FAMOTIDINE, FUROSEMIDE, ALLOPURINOL. Patient died.

Danaparoid Side Effects Report #5033187-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 13, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, gastrointestinal haemorrhage, haemorrhage subcutaneous, platelet count decreased, prothrombin time prolonged. Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM, CIMETIDINE, EPOETIN BETA, HEPARIN. Patient died.

Danaparoid Side Effects Report #5019637-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 24, 2006. Male patient, 64 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood urea increased, cerebral haemorrhage, convulsion, liver disorder, loss of consciousness, prothrombin time prolonged. Danaparoid dosage: unknown. During the same period patient was treated with TRANEXAMIC ACID, CARBAZOCHROME SULFONATE, MENATETRENONE, CEFMETAZOLE, OMEPRAZOLE, PENTAZOCINE LACTATE, HYDROXYZINE HYDROCHLORIDE, DEXAMETHASONE. Patient died.

Danaparoid Side Effects Report #5056234-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2006. Male patient, 43 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, bacteraemia, diarrhoea, enterocolitis, febrile neutropenia, fibrin degradation products increased, platelet count decreased, prothrombin time prolonged, red blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PLASMA PROTEIN FRACTION, TRANEXAMIC ACID, ETOPOSIDE, NOVANTRONE, ISEPAMICIN SULPHATE, CEFTAZIDIME, ALLOPURINOL. Patient recovered.


Danaparoid Side Effects Report #5017007-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Apr 27, 2006. Male patient, 43 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, bacteraemia, enterocolitis, febrile neutropenia, fibrin degradation products increased, platelet count decreased, prothrombin time prolonged, red blood cell count decreased, white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PLASMA PROTEIN FRACTION, TRANEXAMIC ACID, ETOPOSIDE, NOVANTRONE, ISEPAMICIN SULPHATE, CEFTAZIDIME, ALLOPURINOL. Patient recovered.